Opendata, web and dolomites

ExtruLub

Commercialisation of Advanced Extrusion Technologies Delivering Disruptive Innovation for the Next Generation of Catheter Based Medical Devices.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 ExtruLub project word cloud

Explore the words cloud of the ExtruLub project. It provides you a very rough idea of what is the project "ExtruLub" about.

attaining    mn    surfaces    anti    5bn    564mn    catheter    urology    site    international    15    diania    oems    13    hollister    science    eg    21    markets    materials    business    device    market    measured    jobs    alternatives    combined    ambition    extrusion    51    manufacturer    share    resins    command    generate    globally    sub    perspective    sits    polymer    alone    showed    drugs    boston    core    independent    customers    replace    gain    safeguarding    assists    antimicrobial    full    customer    advancing    skilled    reduce    margins    thrombogenic    gross    harnessing    oem    realise    enhancement    lean    medical    generation    functional    facilitates    safety    reducing    patient    170mn    scientific    world    coloplast    applicable    42    30    model    original    preferred    first    protective    manufacturing    whilst    initial    friction    batch    realising    cardiology    function    medtronic    extrulub    surface    supply    disruptive    containment    demonstrated    genuine    equating    grow    engineering    global    line    company    economic    23    chemistry    3mn    savings    innovative    technologies    ca    revenue    2020    differentiation    profile   

Project "ExtruLub" data sheet

The following table provides information about the project.

Coordinator
DIANIA TECHNOLOGIES LIMITED 

Organization address
address: UNIT 120 NUIG BUSINESS INNOVATION CENTRE UPPER NEWCASTLE
city: GALWAY
postcode: H91 Y682
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Ireland [IE]
 Project website http://linkedin.com/company/DiaNia-Technologies
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
2. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2015
 Funding Scheme SME-1
 Starting year 2015
 Duration (year-month-day) from 2015-07-01   to  2015-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    DIANIA TECHNOLOGIES LIMITED IE (GALWAY) coordinator 50˙000.00

Map

 Project objective

ExtruLub is an innovative, disruptive extrusion technology applicable across a range of medical polymer resins, which has the ability to change the surface of a catheter without affecting core device properties. The technology sits in the component sub-supply global market with an initial value of €564mn applicable across all catheter markets (combined value of $42.5bn globally by 2020). From a functional perspective, ExtruLub has the ability to reduce surface friction, generate protective antimicrobial & anti-thrombogenic surfaces & deliver site specific drugs all whilst reducing catheter profile. This enhancement of catheter function assists in safeguarding patient safety & will command genuine product differentiation for the original equipment manufacturer (OEM) of the end device, enabling them to gain market share.From an economic perspective it facilitates a change from lean to batch manufacturing realising cost containment for the target customer.Taking the cardiology sector as an example, an independent study demonstrated ExtruLub would reduce costs for the OEM (eg Boston Scientific, Medtronic etc.) by 51% realising savings of ca. €3mn p.a in one product. In the urology sector, the measured impact showed increased gross margins of ca.13% on one product line alone enabling €21.5 mn p.a. savings for potential customers like Hollister, Coloplast etc. DiaNia Technologies ambition is to grow into a world leading, international technology company, realising market share through disruptive technologies.Our initial goal is to replace current ExtruLub alternatives attaining a 30% market share with the friction product, equating to €170mn in full production.Harnessing advanced polymer chemistry through materials science and engineering has the potential to realise €23.3mn in revenue & 15 new, highly skilled jobs within the first 4 years through a business model preferred by OEMs.This disruptive technology is the key to advancing the next generation of medical devices.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "EXTRULUB" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "EXTRULUB" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.3.1.;H2020-EU.2.1.2.)

INFINITE (2015)

INnovative laser machine For INdustrial engravIng and 3d TExturing

Read More  

FREE-D (2015)

CNC dynamic mold for producing freely curved glass panels

Read More  

S3D (2015)

Feasibility study to determine the use of ITS technology to replace nuclear density meters in mining, dredging and other areas of hydraulic transport.

Read More